| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1958125-89-7 | (R)-2-amino-2-cyclobutylacetic acid hydrochloride | C6H12ClNO2 |
| 1959572-97-4 | Axitinib Impurity C | C15H13N3O2S |
| 1959584-78-1 | Bis(N,N-di-i-propylcarboximidamide)calcium(II) dimer | C28H60Ca2N8 |
| 1960445-63-9 | 2-Bromo-4-chlorodibenzo[b,d]furan | C12H6BrClO |
| 1961266-44-3 | 2,8-Difluoro-5-(trifluoromethyl)-5H-dibenzo[b,d]thiophen-5-ium Trifluoromethanesulfonate | C14H6F8O3S2 |
| 1962925-29-6 | Nirogacestat Hydrobromide | C27H43Br2F2N5O |
| 1965291-08-0 | Ibrexafungerp Citrate | C50H75N5O11 |
| 1966941-11-6 | Rotigotine EP Impurity I | C26H31NO3S2 |
| 1971007-95-0 | N-[[1-(Cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine methyl ester | C23H32N2O3 |
| 1971915-89-5 | 3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid ethyl ester | C19H24N4O5S |
| 1973415-50-7 | (2RS)-Lotaustralin | C11H19NO6 |
| 1974336-09-8 | AB-8939 | C22H24N4O3 |
| 1975982-94-5 | Osimertinib Impurity M | C28H33N7O3 |
| 1977495-97-8 | 7',8'-Dihydro-2'-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]-spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one hydrochloride (1:2) | C24H30N8O .2ClH |
| 1979939-16-6 | N-[(1S)-1-(4-Chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]-3H-imidazo[4,5-b]pyridine-2-propanamide | C25H22ClF3N4O2 |
| 1980023-80-0 | N-[(1S)-1-[6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-3-methyl-5-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-2-pyridinecarboxamide | C26H25FN10O |
| 1980023-94-6 | 1-[6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethanone | C10H8FN3O |
| 1980023-96-8 | (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine | C10H11FN4 |
| 1980023-97-9 | (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine dihydrochloride | C10H13Cl2FN4 |
| 1980063-54-4 | 4-(Difluoromethyl)aniline hydrochloride | C7H8ClF2N |
| 1980785-05-4 | Methanesulfonato(Di-tert-butyl(2',4',6'-triisopropyl-3,6-dimethoxybiphenyl-2-yl)phosphine)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) | C45H65NO5PPdS- |
| 1980814-87-6 | Pitavastatin Impurity 22 | C25H24FNO5 |
| 1980814-90-1 | Pitavastatin Impurity 24 | C25H24FNO6 |
| 1983993-59-4 | trans-5-Butyl-2-(3',5'-difluoro[1,1'-biphenyl]-4-yl)-1,3-dioxane | C20H22F2O2 |
| 1983995-73-8 | trans-5-Butyl-2-(3,5-difluorophenyl)-1,3-dioxane | C14H18F2O2 |
| 1984788-96-6 | 2-Amino-9-[(3aS,4S,6S,6aR)-hexahydro-3a,6-dihydroxy-1H-cyclopenta[c]furan-4-yl]-1,9-dihydro-6H-purin-6-one | C12H15N5O4 |
| 1985605-59-1 | Baloxavir | C24H19F2N3O4S |
| 1985606-14-1 | Baloxavir marboxil | C27H23F2N3O7S |
| 1985606-53-8 | (R)-7-(Benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C31H25F2N3O4S |
| 1985607-70-2 | (12aR)-3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C17H17N3O4 |
| 1985607-83-7 | 7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol | C14H10F2OS |
| 1985638-55-8 | Azilsartan Impurity 96 | C30H24N4O8 |
| 1985668-78-7 | 2-Butyl-1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-1,6-dihydro-N,N,4-trimethyl-6-oxo-5-pyrimidineacetamide | C27H30N4O2 |
| 1987887-92-2 | Nintedanib N-Methyl aniline analog | C24H21N3O3 |
| 1987905-93-0 | Ibrutinib impurity 6 | C47H46N12O3 |
| 1991986-30-1 | 2-[[(4-Methylphenyl)sulfonyl]amino]-N-(4-phenyl-2-thiazolyl)-4-(trifluoromethyl)benzamide | C24H18F3N3O3S2 |
| 1992047-64-9 | MS023 (dihydrochloride) | C17H27Cl2N3O |
| 1996664-59-5 | Zidebactam dihydrate | C13H25N5O9S |
| 1997361-85-9 | Semaglutide Acetate | C189H295N45O61 |
| 1997387-43-5 | N-[(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl]-N'-[(1S)-1-methyl-2-(3-thienyl)ethyl]urea | C19H27N3O2S |
| 2001051-99-4 | Isavuconazole Impurity 23 | C13H12F2N4O |
| 2001052-01-1 | Isavuconazole Impurity 22 | C13H12F2N4O |
| 2001608-72-4 | (3aR,7S,10S,12R,21E,24aR)-7-(1,1-dimethylethyl)-20,20-difluoro-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-5,8-dioxo-10H-9,12-Methano-1H-cyclopenta[18,19][1,10,17,3,6]trioxadiazacyclononadecino[11,12-b]quinoxaline-10-carboxylic acid | C29H34F2N4O7 |
| 2002381-31-7 | 6,7-Dimethoxy-N-(2-methyl-4-phenoxyphenyl)-4-quinazolinamine hydrochloride (1:1) | C23H21N3O3.HCl |
| 2002495-17-0 | 4-Chloro-N-[[3-(1-methylethyl)-5-isoxazolyl]methyl]-3-[(1-methyl-4-piperidinyl)oxy]benzamide | C20H26ClN3O3 |
| 2004659-83-8 | Sorafenib Related Compound 11 | C20H19N5O3 |
| 2004659-84-9 | Sorafenib EP Impurity B | C14H13N3O3 |
| 2004673-44-1 | (3beta,6alpha,12beta,20Z)-3,12,25-Trihydroxydammar-20(22)-en-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside | C42H72O13 |
| 2005443-90-1 | (3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] | C25H24N2O2 |
| 2007909-65-9 | 3-Acetyl-1-azetidinecarboxylic acid phenylmethyl ester | C13H15NO3 |